News
Market and company headlines
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Piper Sandler analyst Jason Bednar maintains Align Technology (NASDAQ:ALGN) with a Overweight and lowers the price target from $235 to $205.

New Report values clear aligners market at $6.09bn in 2026, with dental service organisations and digital orthodontics widening access — though cut-price direct-to-consumer rivals and complex cases test Align Technology, Straumann, Dentsply Sirona and EnvistaDublin, Oct. 20, 2026 (GLOBE NEWSWIRE) -- "Clear Aligners Market: Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. Global Clear Aligners Market to Reach USD 11.04 Billion by 2031 The global clear aligners market
Align Technology is scheduled to report its third-quarter results later this month, and analysts expect a double-digit earnings increase.

Analysts downgraded Envista, Cirrus Logic, ZTO Express, Align Technology and Par Pacific, with mixed price-target changes.

Baird analyst Jeff Johnson downgrades Align Technology (NASDAQ:ALGN) from Outperform to Neutral and lowers the price target from $218 to $162.

Align Technology (NASDAQ:ALGN) shares fell 1. 7% in pre-market trading after Evercore ISI downgraded the medical device company to In Line from Outperform.

U.S. stock futures fell as HubSpot dropped after a downgrade; Roze AI, UMC, Quantum-Si, Intel and others also declined premarket.

Align Technology (ALGN) has put a date on its next checkpoint. The company plans to release third quarter 2026 results on 28 October after the close, with a webcast discussing the figures shortly after. Align Technology enters this earnings date with the share price at about US$145.35, after a slide of around 6% over the past month and roughly 21% over the last quarter. The 1 year total shareholder return of about 12.9% contrasts with a much weaker 3 and 5 year record, suggesting shorter term...

Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TEMPE, Ariz., September 28, 2026--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the launch of SHIFT Happens, a new consumer campaign designed to help Invisalign-trained doctors connect with and educate adult consumers about lifelong tooth movement and explain the

ALGN looks undervalued with strong profitability, no debt, and moderate growth, making Align Technology a potential value stock to watch.

Align Technology has lagged the broader market over the past year, even as Wall Street analysts remain cautiously optimistic about the company’s future prospects.

Align Technology (NASDAQ:ALGN) sees continued growth potential for Invisalign clear aligners in the United States and internationally despite a challenging consumer environment, Chief Financial Officer John Morici said during a Baird investor conference. Morici said inflation and patient reluctance

Align Technology, Inc. (ALGN) 2026 Global Healthcare Conference September 15, 2026 3:10 PM EDTCompany ParticipantsJohn Morici - CFO & Executive VP of...

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
TEMPE, Ariz., September 08, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at

XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
Envista's earnings rebound and raised 2026 guidance strengthen the case, but above-median valuation leaves less room for execution setbacks.
Align Technology (ALGN) appears undervalued with strong profitability, no debt, and decent growth, fitting the Decent Value screen.

Clear aligner volumes hit record levels amid $37.5 million UK VAT liability.

Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows. Read more on ALGN stock here.
